Figure 3.
RACev transplantation improved cardiac function. (A) Schematic of in vivo experiment design. (B–D) Representative echocardiographic images of the Control, MSCev, and RACev groups. (E,F) The RACev transplanted group showed preserved ejection fraction and fractional shortening at 4 weeks. *P < 0.05; ***P < 0.001; ****P < 0.0001 vs. the Control group; ##P < 0.01; ###P < 0.001 vs. the MSCev group. Scale bar = 100 μm Statistical significance was determined using 2-way ANOVA followed by Tukey's multiple comparison post-hoc test. The results are presented as mean ± SEM. (n = 8–10 per group). EchoCG, echocardiography; EV, extracellular vesicles; M-IRI, myocardial ischemic reperfusion injury; Tx, transplantation; 500K is 5 x 105 either RACs or MSCs-derived EVs.
